It’s projected that by 2027, 56% of total insurance spend will go to specialty medications. But what if that same slice could be shrunk down to just 17%?
That’s not fantasy. That’s what we do. Aphora Health saves companies up to 70% on Specialty Medications.
It’s projected that by 2027, 56% of total insurance spend will go to specialty medications.
That's not a typo. Over half.
Specialty drugs have exploded in scope and impact. There were fewer than a dozen in circulation in the early ’90s. Today, there are hundreds, and that list now includes GLP-1s like Wegovy® and Ozempic®.
They don't just carry hefty price tags. They're stress tests on your budget.
But what if that same slice could be shrunk down to just 17%?
That’s not fantasy. That’s what we do. Aphora Health saves companies up to 70% on Specialty Medications.
So, where’s that 17% number coming from? If we save you 70% on the specialty meds taking up 56% of your budget... Well, feel free to break out your calculator alongside ours, but the way that math works out is that we can free up around 40% of your total spend.
At Aphora Health, we specialize in helping self-funded employers take back control of specialty spend, without sacrificing care or quality.
We don’t just negotiate a better deal. We:
Our clients routinely save up to 70% on specialty medication costs, often without employees even noticing the behind-the-scenes work.
If you’re watching your total claims cost creep up year after year, know this: you’re not imagining it. And the specialty category is the root cause.
But you don’t have to sit back and wait for that 56% to hit.
Aphora Health clients spend closer to 16.8% — and that number keeps shrinking with every optimization we uncover.
Reach out today: https://aphorahealth.com/analysis-request — and let’s find out what your 2027 could look like with specialty costs finally under control.
.png)
.svg)
.svg)
